A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder

Journal of Clinical Psychiatry

Volumn 60, Issue 2, 1999, Pages 101-106

  Pigott, Teresa A ^a   Seay, Sheila M ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRY EYE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSESSION; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0032965623     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v60n0206     Document Type: Article

References (50)

1. Veale D. How to recognize and treat obsessive-compulsive disorder. Int Monitor 1994;13:79-82
2. Zetin M, Kramer M. Obsessive-compulsive disorder. Hosp Community Psychiatry 1992;43:689-699
3. Rapaport JL, Leonard HL, Swedo SE, et al. Obsessive compulsive disorder in children and adolescents: issues in management. J Clin Psychiatry 1993;54(6, suppl):27-29
4. Lal N, Agarwal A, Sinha P. Perception of distress by obsessive compulsive patients. Indian J Psychiatry 1986;28:311-316
5. Chakrabarti S, Kulhara P, Verma S. The pattern of burden in families of neurotic patients. Soc Psychiatry Psychiatr Epidemiol 1993;28:172-177
6. Karno M, Golding J, Sorenson S, et al. The epidemiology of OCD in five US communities. Arch Gen Psychiatry 1988;45:1094-1099
7. Weissman MM, Bland RC, Canino GJ, et al. The cross national epidemiology of obsessive compulsive disorder. J Clin Psychiatry 1994;55 (3, suppl):5-10
8. Jenike M. Obsessive compulsive and related disorders: a hidden epidemic. N Engl J Med 1989;321:539-541
9. Nelson E, Rice J. Stability of diagnosis of obsessive-compulsive disorder in the Epidemiologic Catchment Area study. Am J Psychiatry 1997;154: 826-831
10. Richelson E. Synaptic pharmacology of antidepressants: an update. McLean Hosp J 1988;43:6-16
11. Benfield D, Harris C, Luscombe D. Some psychopharmacological aspects of desmethylclomipramine. Postgrad Med 1980;56:13-18
12. Rasmussen SA, Eisen JL, Pato MT. Current issues in the pharmacologic management of obsessive compulsive disorder. J Clin Psychiatry 1993; 54(6, suppl):4-9. Correction 1993;54:491
13. Zohar J, Insel T. OCD: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol Psychiatry 1987;22:667-687
14. Insel T, Mueller E, Alterman I, et al. OCD and serotonin: is there a connection? Biol Psychiatry 1985;20:1174-1188
15. Goodman WK, Delgado PL, Price LH. Specificity of serotonin reuptake inhibitors in the treatment of OCD: comparison of fluvoxamine and desipramine in OCD. Arch Gen Psychiatry 1990;47:577-585
16. Murphy DL, Pigott TA. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety. J Clin Psychiatry 1990;51(4, suppl):53-58
17. Jenike M, Hyman S, Baer L, et al. A controlled trial of fluvoxamine in OCD: implications for a serotonergic theory. Am J Psychiatry 1989;147: 1209-1215
18. Hall H, Ogren S. Effects of antidepressant drugs on different receptors in the rat brain. Eur J Pharmacol 1981;70:393-407
19. Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with OCD. Arch Gen Psychiatry 1991;48:730-738
20. DeVeaugh-Greiss J, Landau P, Katz R. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder. Psychopharmacol Bull 1989;25:36-40
21. Goodman WK, McDougle CJ, Price LH. Pharmacotherapy of obsessive compulsive disorder. J Clin Psychiatry 1992;53(4, suppl):29-37
22. Jenike MA, Baer L, Greist JH. Clomipramine versus fluoxetine in OCD: a retrospective comparison of side effects and efficacy. J Clin Psychopharmacol 1990;10:122-124
23. Stern R, Marks I, Wright J, et al. Clomipramine: plasma levels, side effects, and outcome in obsessive-compulsive neurosis. Postgrad Med J 1980;56(suppl 1):134-139
24. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive-Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011
25. Mavissakalian M, Turner S, Michelson L, et al. Tricyclic antidepressants in OCD: antiobsessional or antidepressant agents? Am J Psychiatry 1985; 142:572-576
26. Feinberg M. Clomipramine for obsessive-compulsive disorder. Am Fam Physician 1991;43:1735-1737
27. Stark P, Hardison CD. A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 1985;46:53-58
28. Richelson E. Biological basis of depression and therapeutic relevance. J Clin Psychiatry 1991;52(6, suppl):4-10. Correction 1991;52:353
29. Tollefson G, Rampey A, Potvin J, et al. A multicenter investigation of fixed-dose fluoxetine in the treatment of OCD. Arch Gen Psychiatry 1994;51:559-567
30. Greist JH, Chouinard G, DuBoff E, et al. A double-blind comparison of three doses of sertraline in outpatients with OCD. Arch Gen Psychiatry 1995;52:289-295
31. Rasmussen S, Goodman W, Greist J, et al. Fluvoxamine in the treatment of OCD: a multicenter double-blind, placebo-controlled study in outpatients. Am J Psychiatry. In press
32. Wheadon D, Bushnell W, Steiner M. A fixed-dose comparison of 20, 40 or 60 mg paroxetine to placebo in the treatment of OCD. In: Abstracts of the 32nd Annual Meeting of the American College of Neuropharmacology; December 1993; Honolulu, Hawaii
33. Greist J, Jefferson J, Koback K, et al. Efficacy and tolerability of serotonin transport inhibitors in OCD: a meta-analysis. Arch Gen Psychiatry 1995; 52:53-60
34. Pigott TA, Pato MT, Bernstein SE, et al. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1990;47:926-930
35. Smeraldi E, Erzegovesi S, Blanchi I, et al. Fluvoxamine versus clomipramine treatment in OCD: a preliminary study. New Trends Exp Clin Psychiatry 1992;8:63-65
36. Freeman CPL, Trimble MR, Deakin JFW, et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. J Clin Psychiatry 1994;55:301-305
37. Koran LM, McElroy SL, Davidson JRT, et al. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. J Clin Psychopharmacol 1996;16:121-129
38. Lopez-Ibor JJ Jr, Saiz J, Cottraux J, et al. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder. Eur Neuropsychopharmacol 1996;6(2):111-118
39. Bisserbe J-C, Lane RM, Flament MF, and the Franco-Belgian OCD Study Group. A double-blind comparison of sertraline and clomipramine in out-patients with obsessive-compulsive disorder. Eur Psychiatry 1997;12: 82-93
40. Zohar J, Judge R, and the OCD Paroxetine Study Investigators. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. Br J Psychiatry 1996;169:468-174
41. Piccinelli M, Pini S, Bellantuono C, et al. Efficacy of drug treatment in OCD: a meta-analytic review. Br J Psychiatry 1995;166:424-443
42. Jenike MA, Baer L, Greist JH. Clomipramine versus fluoxetine in OCD: a retrospective comparison of side effects and efficacy. J Clin Psychopharmacol 1990;10:122-124
43. Anderson I, Tomenson B. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 1995;310:1433-1438
44. Ananth J. Clomipramine: an antiobsessive drug. Can J Psychiatry 1986; 31:253-258
45. Asberg M, Thoren P, Bertilsson L. Clomipramine treatment of OCD: biochemical and clinical aspects. Psychopharmacol Bull 1982;18:13-21
46. Thoren P, Asberg M, Crohnholm B, et al. Clomipramine treatment of OCD, I: a controlled clinical trial. Arch Gen Psychiatry 1980;37:1281-1285
47. Tollefson GD, Birkett M, Koran L, et al. Continuation treatment of OCD: a double-blind and open-label experience with fluoxetine. J Clin Psychiatry 1994;55(10, suppl):69-78
48. Greist JH, Jefferson JW, Kobak AK, et al. A 1-year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive compulsive disorder. Int Clin Psychopharmacol 1995;10:57-65
49. Steiner M, Bushnell WD, Gergel IP, et al. Long-term treatment and prevention of relapse of OCD with paroxetine. In: New Research Program and Abstracts of the 1995 Annual Meeting of the American Psychiatric Association: May 24, 1995; Miami, Fla. Abstract NR354:150
50. Ravizza L, Barzega G, Bellino S, et al. Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs). Psychopharmacol Bull 1996;32(1): 167-173